Application
Western blot analysis of Bcl-2 expression in non-transfected: (A) and human Bcl-2 transfected: (B) 293T whole cell lysates.Application
Western blot analysis of Bcl-2 expression in HL-60 whole cell lysate.Application
Western blot analysis of Bcl-2 expression in non-transfected: (A) and mouse Bcl-2 transfected: (B) 293T whole cell lysates.Application
Antibodies tested include Bcl-2 (100): (A-C) and Bcl-2 (N-19): (D-F).Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human tonsil tissue showing cytoplasmic staining (A). Immunofluorescence staining of methanol-fixed HL-60 cells showing cytoplasmic localization (B).| Product Name | Bcl-2 Antibody (N-19) HRP |
|---|---|
| Antibody Type | Primary Antibodies |
| Modification Notes | Apoptosis is defined as a set of cascades which, when initiated, programs the cell to undergo lethal changes such as membrane blebbing, mitochondrial break down and DNA fragmentation. Bcl-2 is one among many key regulators of apoptosis, which are essential for proper development, tissue homeostasis, and protection against foreign pathogens. Human Bcl-2 is an anti-apoptotic, membrane-associated oncoprotein that can promote cell survival through protein-protein interactions with other Bcl-2 related family members, such as the death suppressors Bcl-xl, Mcl-1, Bcl-w, and A1 or the death agonists Bax, Bak, Bik, Bad, and Bid. The anti-apoptotic function of Bcl-2 can also be regulated through proteolytic processing and phospho-rylation. Bcl-2 may promote cell survival by interfering with the activation of the cytochrome c/Apaf-1 pathway through stabilization of the mitochondrial membrane. Mutations in the Bcl-2 gene can contribute to cancers where normal physiological cell death mechanisms are compromised by deregulation of the anti-apoptotic influence of Bcl-2. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIPIFIHCELISA |
| recommended for detection of Bcl-2 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA also reactive with additional species, including equine, canine, bovine and porcine | |
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Alternative Names | epitope mapping at the N-terminus of Bcl-2 of human origin |
|---|---|
| Tissue Specificity | epitope mapping at the N-terminus of Bcl-2 of human origin |
| Entrez Gene | 596 |
|---|
Application
Western blot analysis of Bcl-2 expression in non-transfected: (A) and human Bcl-2 transfected: (B) 293T whole cell lysates.
Application
Western blot analysis of Bcl-2 expression in HL-60 whole cell lysate.
Application
Western blot analysis of Bcl-2 expression in non-transfected: (A) and mouse Bcl-2 transfected: (B) 293T whole cell lysates.
Application
Antibodies tested include Bcl-2 (100): (A-C) and Bcl-2 (N-19): (D-F).
Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human tonsil tissue showing cytoplasmic staining (A). Immunofluorescence staining of methanol-fixed HL-60 cells showing cytoplasmic localization (B).| Application Notes | recommended for detection of Bcl-2 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA also reactive with additional species, including equine, canine, bovine and porcine |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
